To investigate the safety and pharmacokinetics of S-222611

• Research type

  Research Study

• Full title

  A Phase I single-dose, double-blind, placebo-controlled study in healthy adult subjects to assess the safety and pharmacokinetics of S-222611

• IRAS ID

  14531

• Sponsor organisation

  Shionogi & Co., Ltd.

• Eudract number

  2008-008205-21

• ISRCTN Number

  No number provided

• Clinicaltrials.gov Identifier

  No number provided

• Research summary

  To investigate the tolerability and safety of a range of single oral doses of S-222611 in healthy young male volunteers.

• REC name

  London - London Bridge Research Ethics Committee

• REC reference

  09/H0804/4

• Date of REC Opinion

  2 Feb 2009

• REC opinion

  Favourable Opinion